ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,707 | -33.1% | 360 | -6.7% | 0.00% | – |
Q2 2023 | $10,028 | +29394.1% | 386 | -67.5% | 0.00% | – |
Q1 2023 | $34 | -2.9% | 1,186 | 0.0% | 0.00% | – |
Q4 2022 | $35 | -99.9% | 1,186 | 0.0% | 0.00% | – |
Q3 2022 | $30,000 | +15.4% | 1,186 | +2.2% | 0.00% | – |
Q2 2022 | $26,000 | -10.3% | 1,160 | 0.0% | 0.00% | – |
Q1 2022 | $29,000 | -48.2% | 1,160 | -11.5% | 0.00% | – |
Q3 2021 | $56,000 | -1.8% | 1,310 | 0.0% | 0.00% | – |
Q2 2021 | $57,000 | +7.5% | 1,310 | 0.0% | 0.00% | – |
Q1 2021 | $53,000 | -10.2% | 1,310 | 0.0% | 0.00% | – |
Q4 2020 | $59,000 | +43.9% | 1,310 | +12.9% | 0.00% | – |
Q3 2020 | $41,000 | -63.4% | 1,160 | -61.0% | 0.00% | -100.0% |
Q2 2020 | $112,000 | +47.4% | 2,974 | +12.7% | 0.00% | 0.0% |
Q1 2020 | $76,000 | -46.5% | 2,640 | -3.6% | 0.00% | 0.0% |
Q4 2019 | $142,000 | -5.3% | 2,740 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $150,000 | +233.3% | 2,740 | +146.8% | 0.00% | – |
Q2 2019 | $45,000 | +32.4% | 1,110 | 0.0% | 0.00% | – |
Q1 2019 | $34,000 | -8.1% | 1,110 | 0.0% | 0.00% | – |
Q4 2018 | $37,000 | -78.1% | 1,110 | -72.3% | 0.00% | -100.0% |
Q3 2018 | $169,000 | +207.3% | 4,010 | +134.5% | 0.00% | +100.0% |
Q2 2018 | $55,000 | -38.2% | 1,710 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $89,000 | -71.1% | 1,710 | -70.1% | 0.00% | -66.7% |
Q4 2017 | $308,000 | -20.8% | 5,710 | -14.9% | 0.00% | -25.0% |
Q3 2017 | $389,000 | +23.1% | 6,710 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $316,000 | +8.6% | 6,710 | 0.0% | 0.00% | +33.3% |
Q1 2017 | $291,000 | -13.9% | 6,710 | -2.8% | 0.00% | -25.0% |
Q4 2016 | $338,000 | -28.7% | 6,900 | -30.3% | 0.00% | -33.3% |
Q3 2016 | $474,000 | -22.5% | 9,900 | -13.2% | 0.01% | -25.0% |
Q2 2016 | $612,000 | +20.0% | 11,400 | 0.0% | 0.01% | +14.3% |
Q1 2016 | $510,000 | +17.2% | 11,400 | 0.0% | 0.01% | +16.7% |
Q4 2015 | $435,000 | +17.3% | 11,400 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $371,000 | +33.9% | 11,400 | +35.7% | 0.01% | +50.0% |
Q2 2015 | $277,000 | -19.9% | 8,400 | 0.0% | 0.00% | -20.0% |
Q1 2015 | $346,000 | +6.1% | 8,400 | +5.0% | 0.01% | +25.0% |
Q4 2014 | $326,000 | -6.3% | 8,000 | -15.8% | 0.00% | -20.0% |
Q3 2014 | $348,000 | -20.9% | 9,500 | 0.0% | 0.01% | -16.7% |
Q2 2014 | $440,000 | -7.0% | 9,500 | -17.4% | 0.01% | -14.3% |
Q1 2014 | $473,000 | – | 11,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |